Loading clinical trials...
Loading clinical trials...
ATRX (X-linked mental retardation and alpha-thalassaemia syndrome protein) loss and pTERT (Telomerase reverse transcriptase) mutation are diagnostic markers of gliomas. However, 4 to 28% of gliomas sh...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hospices Civils de Lyon
NCT04166409 · Low Grade Astrocytoma, Low Grade Glioma, and more
NCT05804227 · Gliomas
NCT07464925 · Glioblastoma Multiforme of Brain, Glioma, and more
NCT07450872 · Cancer, Glioma, and more
NCT06883214 · Glioma
Institut de Pathologie Est, Biopathologie moléculaire, Hôpitaux Est, HCL
Bron
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions